Kestra Private Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kestra Private Wealth Services's BMY Position: Q2 2026 in Review
Kestra Private Wealth Services reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, selling an estimated $1.1M and leaving 151,030 shares worth $8.7M. The position accounts for 0.1% of the portfolio, ranked #226.
Kestra Private Wealth Services first reported a position in BMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $10.4M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Kestra Private Wealth Services held 151,030 shares of Bristol-Myers Squibb worth $8.7M as of Q2 2026.
- Kestra Private Wealth Services sold 19,213 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.1M.
- Bristol-Myers Squibb made up 0.1% of Kestra Private Wealth Services's portfolio in Q2 2026, its #226 holding.
- Kestra Private Wealth Services first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 24 quarters since.
- Kestra Private Wealth Services's Bristol-Myers Squibb position peaked at $10.4M in Q1 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.